Model of translational cancer research in multiple myeloma

Recently, intensive laboratory and preclinical studies have identified and validated therapeutic molecular targets in multiple myeloma (MM). The introduction of novel agents such as the proteasome inhibitor bortezomib and the immunomodulatory drugs thalidomide and lenalidomide, which were rapidly tr...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Yasui, Hiroshi, Ishida, Tadao, Maruyama, Reo, Nojima, Masanori, Ikeda, Hiroshi, Suzuki, Hiromu, Hayashi, Toshiaki, Shinomura, Yasuhisa, Imai, Kohzoh
Format: Artigo
Idioma:Inglês
Publicat: Blackwell Publishing Ltd 2012
Matèries:
Review Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3533800/
https://ncbi.nlm.nih.gov/pubmed/22809142
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1349-7006.2012.02384.x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars